No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs143171342 |
chr9:103490840-103490841 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs9299341 |
chr9:103490884-103490885 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
3 |
rs118186494 |
chr9:103490890-103490891 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs549394130 |
chr9:103490915-103490916 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs563384080 |
chr9:103490930-103490931 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs545636768 |
chr9:103490947-103490948 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs372635715 |
chr9:103490976-103490977 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs528017995 |
chr9:103490998-103490999 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs541223584 |
chr9:103491049-103491050 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs4237199 |
chr9:103491071-103491072 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs530121182 |
chr9:103491100-103491101 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs147512257 |
chr9:103491113-103491114 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs532077673 |
chr9:103491145-103491146 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs557218593 |
chr9:103491154-103491155 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs570007598 |
chr9:103491167-103491168 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs532402781 |
chr9:103491202-103491203 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs57746575 |
chr9:103491314-103491315 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs369519572 |
chr9:103491315-103491316 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs397705497 |
chr9:103491324-103491325 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs547064403 |
chr9:103491339-103491340 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs571553093 |
chr9:103491377-103491378 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs534126196 |
chr9:103491448-103491449 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs73497675 |
chr9:103491490-103491491 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
24 |
rs183960661 |
chr9:103491520-103491521 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs536317509 |
chr9:103491606-103491607 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs4543599 |
chr9:103491608-103491609 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
27 |
rs557772771 |
chr9:103491616-103491617 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs140142746 |
chr9:103491635-103491636 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs539574720 |
chr9:103491681-103491682 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs544670054 |
chr9:103491697-103491698 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs558571295 |
chr9:103491728-103491729 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs572385045 |
chr9:103491840-103491841 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs190433571 |
chr9:103491870-103491871 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs181658216 |
chr9:103491901-103491902 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs556284111 |
chr9:103491903-103491904 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs369801115 |
chr9:103491909-103491910 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs551410690 |
chr9:103491915-103491916 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs561112956 |
chr9:103492056-103492057 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs530254860 |
chr9:103492074-103492075 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs398039675 |
chr9:103492083-103492084 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs543850370 |
chr9:103492148-103492149 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs187615854 |
chr9:103492168-103492169 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs144094406 |
chr9:103492196-103492197 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs552283601 |
chr9:103492206-103492207 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs554972709 |
chr9:103492241-103492242 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs199562583 |
chr9:103492288-103492289 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs190450022 |
chr9:103492327-103492328 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs573298987 |
chr9:103492393-103492394 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs527568967 |
chr9:103492396-103492397 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs181836663 |
chr9:103492438-103492439 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|